Monday, May 29, 2017

Antibiotic Resistance Is Accelerating Near Pharmaceutical Factories


By Dr. Mercola Nearly half of Americans took at least one prescription drug in the past 30 days,1 but chances are most of them did not give much thought to where those drugs came from. Unbeknownst to many, most drugs taken by Americans are not made in the U.S. but, rather, come from bulk drug manufacturing facilities in places like China and India. Hyderabad, India, is one particularly prolific city for these bulk drug manufacturers, producing 50 percent of India's drug exports.2 The U.S. Food and Drug Administration (FDA) and other international regulatory bodies like the European Medicines Agency require such manufacturers to follow Good Manufacturing Practices (GMP) to ensure drug safety, but there is a glaring omission from these guidelines: They do not consider the environment. As such, massive amounts of pharmaceutical waste — perhaps thousands of tons a day — are entering waterways near the facilities and, according to new research published in the journal Infection, result
http://articles.mercola.com/sites/articles/archive/2017/05/30/antibiotic-resistance-accelerating-near-pharmaceutical-factories.aspx

No comments:

Post a Comment